Massachusetts Financial Services CO Biogen Inc. Transaction History

Massachusetts Financial Services CO

$314 Billion
Q2 2024

A detailed history of Massachusetts Financial Services CO transactions in Biogen Inc. stock. As of the latest transaction made, Massachusetts Financial Services CO holds 548,673 shares of BIIB stock, worth $101 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

548,673

Previous 574,975 4.57%

Holding current value

$101 Million

Previous $124 Million 2.59%

% of portfolio

0.04%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$190.52 - $236.72 $5.01 Million - $6.23 Million	-26,302 Reduced 4.57%	548,673 $127 Million
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $1.08 Million - $1.36 Million	-5,090 Reduced 0.88%	574,975 $124 Million
Q4 2023 Feb 08, 2024	BUY	$222.59 - $267.94 $29.7 Million - $35.8 Million	133,463 Added 29.88%	580,065 $150 Million
Q3 2023 Nov 08, 2023	BUY	$253.3 - $285.89 $76 Million - $85.8 Million	300,086 Added 204.81%	446,602 $115 Million
Q2 2023 Aug 09, 2023	SELL	$275.25 - $318.06 $157,167 - $181,612	-571 Reduced 0.39%	146,516 $41.7 Million
Q1 2023 May 10, 2023	SELL	$256.56 - $292.34 $118,530 - $135,061	-462 Reduced 0.31%	147,087 $40.9 Million
Q4 2022 Feb 13, 2023	SELL	$252.44 - $306.72 $20.3 Million - $24.7 Million	-80,471 Reduced 35.29%	147,549 $40.9 Million
Q3 2022 Nov 09, 2022	BUY	$194.69 - $268.46 $10.9 Million - $15 Million	55,837 Added 32.43%	228,020 $60.9 Million
Q2 2022 Aug 09, 2022	SELL	$187.54 - $223.02 $6.26 Million - $7.44 Million	-33,373 Reduced 16.24%	172,183 $35.1 Million
Q1 2022 May 11, 2022	SELL	$193.77 - $244.14 $772,560 - $973,386	-3,987 Reduced 1.9%	205,556 $43.3 Million
Q4 2021 Feb 10, 2022	BUY	$223.92 - $287.77 $1.25 Million - $1.6 Million	5,561 Added 2.73%	209,543 $50.3 Million
Q3 2021 Nov 10, 2021	BUY	$282.99 - $369.05 $29.7 Million - $38.7 Million	104,969 Added 106.02%	203,982 $57.7 Million
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $16.5 Million - $26.4 Million	63,556 Added 179.25%	99,013 $34.3 Million
Q1 2021 May 13, 2021	SELL	$242.95 - $284.63 $8.33 Million - $9.76 Million	-34,295 Reduced 49.17%	35,457 $9.92 Million
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $12.3 Million - $18.5 Million	-52,098 Reduced 42.76%	69,752 $17.1 Million
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $17 Million - $19.7 Million	-64,338 Reduced 34.56%	121,850 $34.6 Million
Q2 2020 Aug 11, 2020	SELL	$258.66 - $342.55 $9.31 Million - $12.3 Million	-35,986 Reduced 16.2%	186,188 $49.8 Million
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $21.1 Million - $26.8 Million	-78,559 Reduced 26.12%	222,174 $70.3 Million
Q4 2019 Feb 13, 2020	SELL	$220.06 - $304.07 $34.8 Million - $48.1 Million	-158,343 Reduced 34.49%	300,733 $89.2 Million
Q3 2019 Nov 05, 2019	SELL	$217.44 - $243.88 $95.7 Million - $107 Million	-440,319 Reduced 48.96%	459,076 $107 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $205 Million - $226 Million	-934,178 Reduced 50.95%	899,395 $210 Million
Q1 2019 May 13, 2019	SELL	$216.71 - $338.96 $16.5 Million - $25.8 Million	-75,998 Reduced 3.98%	1,833,573 $433 Million
Q4 2018 Feb 08, 2019	BUY	$278.5 - $352.75 $13.1 Million - $16.6 Million	47,142 Added 2.53%	1,909,571 $575 Million
Q3 2018 Oct 25, 2018	SELL	$293.51 - $383.83 $68.3 Million - $89.3 Million	-232,576 Reduced 11.1%	1,862,429 $658 Million
Q2 2018 Jul 30, 2018	BUY	$257.52 - $306.91 $4.84 Million - $5.77 Million	18,790 Added 0.91%	2,095,005 $608 Million
Q1 2018 May 04, 2018	BUY	$260.13 - $367.91 $64.1 Million - $90.7 Million	246,436 Added 13.47%	2,076,215 $569 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $11.7 Million - $13.1 Million	37,909 Added 2.12%	1,829,779 $583 Million
Q3 2017 Nov 14, 2017	SELL	$281.15 - $329.69 $13.4 Million - $15.7 Million	-47,712 Reduced 2.59%	1,791,870 $561 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,839,582	1,839,582 $499 Million

Others Institutions Holding BIIB

# of Institutions

1,049

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $26.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Account

Massachusetts Financial Services CO Biogen Inc. Transaction History